Screener
iRadimed IRMD Operating Cash Flow
Operating Cash Flow at other companies
Other financials
Where this comes from
Reported directly by iRadimed in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.
The source filing: iRadimed’s 10-Q, filed May 1, 2026.
- Filed
- May 1, 2026, 4:08 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-029325
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Deferred revenue | 305 | 547 |
| Other current liabilities | — | (150) |
| Accrued income taxes | 2,088 | 584 |
| Net cash provided by operating activities | 8,290 | 4,292 |
| Investing activities: | ||
| Purchases of property and equipment | (403) | (3,697) |
| Capitalized intangible assets | (66) | (220) |
| Net cash used in investing activities | (469) | (3,917) |
Item 1. Condensed Financial Statements
FAQ
- What is iRadimed's operating cash flow?
- iRadimed (IRMD) reported operating cash flow of $8.29M in Q1 2026.
- How has iRadimed's operating cash flow changed year-over-year?
- iRadimed's operating cash flow increased by 93.2% year-over-year, from $4.29M to $8.29M.
- What is the long-term trend for iRadimed's operating cash flow?
- Over 4 years (2021 to 2025), iRadimed's operating cash flow has grown at a 22.0% compound annual growth rate (CAGR), from $11.26M to $24.95M.
- What does operating cash flow mean?
- Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.
Ask your AI about iRadimed's operating cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude